The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers
University of Utah
Summary
The purpose of this clinical trial is to learn if the drug guarana improves symptoms of fatigue in patients with neuroendocrine tumors and gynecologic cancers
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * Subjects aged ≥ 18 years. * Cohort A (Neuroendocrine Tumor) Only: ---Subjects with unresected locally advanced or metastatic well differentiated neuroendocrine tumors who are either on a watch- and-wait approach or receiving treatment with somatostatin analog(s). Patient who received and completed another active treatment but are on a "break" from treatment will be allowed to enroll (e.g., patients that had completed PRRT). * Cohort B (Gynecological Cancer) Only: ---Subjects with early-stage (I or II) ovarian/fallopian-tube cancer in surveillance who have completed…
Interventions
- DrugGuarana
500 mg oral medication daily
- DrugPlacebo
Oral medication daily
Location
- Huntsman Cancer Institute at University of UtahSalt Lake City, Utah